±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 662  |  »Ø¸´: 1

zoujing10

Í­³æ (СÓÐÃûÆø)

[ÇóÖú] ¾«°±Ëá²¼Âå·ÒĬ¿ËË÷Òý

Ë­ÊÖÉÏÓÐĬ¿ËË÷Òý£¬°ïÎÒ²éһϾ«°±Ëá²¼Âå·ÒµÄÄÚÈÝ
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¹²Í¬Ñ§Ï°£¬¹²Í¬½ø²½
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mouse103

ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+3, 3Q 2012-08-09 11:09:11
zoujing10: ½ð±Ò+10 2012-08-23 14:53:02
Structural Formula Vector Image

Title: Ibuprofen
CAS Registry Number: 15687-27-1
CAS Name: a-Methyl-4-(2-methylpropyl)benzeneacetic acid
Additional Names: p-isobutylhydratropic acid; (¡À)-2-(4-isobutylphenyl)propionic acid
Manufacturers' Codes: RD-13621
Trademarks: Advil (Wyeth); Brufen (Abbott); Brufort (Lampugnani); Dolgit (Dolorgiet); Dolocyl (Novartis); Epobron (Ono); Fenbid (Goldshield); Gynofug (Wolff); Ibumetin (Nycomed); Ibutop (Dolorgiet); Ipren (Pharmacia); Motrin (McNeil); Napacetin (Toyama); Novogent (Temmler); Nuprin (BMS); Nurofen (Boots); Opturem (Kade); Proflex (Novartis); Solufen (SMB); Tabalon (Teofarma); Urem (Kade)
Molecular Formula: C13H18O2
Molecular Weight: 206.28
Percent Composition: C 75.69%, H 8.80%, O 15.51%
Literature References: Nonsteroidal anti-inflammatory drug (NSAID); activity resides primarily in the (S)-isomer. Prepn: J. S. Nicholson, S. S. Adams, GB 971700; eidem, US 3385886 (1964, 1968 both to Boots Pure Drug); T. Shiori, N. Kawai, J. Org. Chem. 43, 2936 (1978); J. T. Pinhey, B. A. Rowe, Tetrahedron Lett. 21, 965 (1980). Methods for resolution of enantiomers: R. Bhushan, J. Martens, Biomed. Chromatogr. 12, 309 (1998). HPLC determn in plasma: R. Canaparo et al., ibid. 14, 219 (2000). Pharmacology: S. S. Adams et al., Arch. Int. Pharmacodyn. Ther. 178, 115 (1969). Acute toxicity: G. Orzalesi et al., Arzneim.-Forsch. 27, 1006 (1977). Clinical trial for closure of patent ductus arteriosus: B. Van Overmeire et al., N. Engl. J. Med. 343, 674 (2000). Review of pharmacology and clinical experience: M. Busson et al., J. Int. Med. Res. 14, 53-62 (1986); of clinical pharmacokinetics and metabolism: N. M. Davies, Clin. Pharmacokinet. 34, 101-154 (1998).
Properties: Colorless, crystalline stable solid, mp 75-77¡ã. Relatively insol in water. Readily sol in most organic solvents. LD50 in male mice, rats (mg/kg): 495, 626 i.p.; 1255, 1050 orally (Orzalesi).
Melting point: mp 75-77¡ã
Toxicity data: LD50 in male mice, rats (mg/kg): 495, 626 i.p.; 1255, 1050 orally (Orzalesi)

Derivative Type: Lysine salt
Trademarks: Arfen (Lisapharma); Imbun (Merckle)
Molecular Formula: C13H18O2.C6H14N2O2
Molecular Weight: 352.47
Percent Composition: C 64.74%, H 9.15%, O 18.16%, N 7.95%

Derivative Type: S-Form L-lysine salt monohydrate
CAS Registry Number: 141505-32-0
Additional Names: Dexibuprofen lysine
Manufacturers' Codes: MK-223
Molecular Formula: C13H18O2.C6H14N2O2.H2O
Molecular Weight: 370.48
Percent Composition: C 61.60%, H 9.25%, O 21.59%, N 7.56%

Therap-Cat: Anti-inflammatory; analgesic; antipyretic.
Therap-Cat-Vet: Anti-inflammatory.
Keywords: Anti-inflammatory (Nonsteroidal); Arylpropionic Acid Derivatives.
2Â¥2012-08-09 11:01:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zoujing10 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 340Çóµ÷¼Á +5 jhx777 2026-03-27 5/250 2026-03-28 04:18 by fmesaito
[¿¼ÑÐ] 295²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +6 1428151015 2026-03-27 6/300 2026-03-28 03:51 by fmesaito
[¿¼ÑÐ] 286Çóµ÷¼Á +3 ¶ªµôÀÁ¶è 2026-03-27 6/300 2026-03-27 23:46 by barnett0632
[¿¼ÑÐ] 265Çóµ÷¼Á +8 Сľ³æ085600 2026-03-27 8/400 2026-03-27 22:16 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 277¹òÇóµ÷¼Á +5 1915668 2026-03-27 8/400 2026-03-27 19:53 by WYUMater
[¿¼ÑÐ] 322Çóµ÷¼Á +4 ¾É… 2026-03-24 4/200 2026-03-27 15:38 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +10 A-¶ßÀ²ZÃÎ 2026-03-23 16/800 2026-03-27 15:13 by caszguilin
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤°²È«¹¤³Ì300·Ö£¬Çóµ÷¼Á +4 0857Çóµ÷¼Á. 2026-03-24 4/200 2026-03-27 14:03 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-27 3/150 2026-03-27 10:17 by guoweigw
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +4 ´Þwj 2026-03-26 4/200 2026-03-27 08:04 by chemisry
[¿¼ÑÐ] 294·Ö080500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +4 ÁøÏª±ß 2026-03-26 4/200 2026-03-26 21:14 by XPUÀîÇì
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-03-26 3/150 2026-03-26 19:57 by nihaoar
[¿¼ÑÐ] 297Çóµ÷¼Á +6 ÌïºéÓÐ 2026-03-26 6/300 2026-03-26 15:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ѰÕÒµ÷¼Á +5 ¾óǿâ? 2026-03-21 8/400 2026-03-26 13:25 by 0906ljy
[¿¼ÑÐ] 309Çóµ÷¼Á +4 gajsj 2026-03-25 5/250 2026-03-26 00:27 by Dyhoer
[¿¼ÑÐ] 302Çóµ÷¼Á +4 ½õÒÂÎÀÌÙ½· 2026-03-25 4/200 2026-03-25 16:29 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] ¡¾2026¿¼Ñе÷¼Á¡¿ÖÆÒ©¹¤³Ì 284·Ö ÇóÏà¹Ø×¨Òµµ÷¼ÁÃû¶î +4 Ô¬Û¼Û¼ 2026-03-25 8/400 2026-03-25 14:32 by lbsjt
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼ÁÉú +3 »ÆÁ»Ò»ÃÎǧÄê 2026-03-24 3/150 2026-03-24 17:00 by barlinike
[¿¼ÑÐ] 336»¯¹¤µ÷¼Á +4 Íõ´ó̹1 2026-03-23 5/250 2026-03-23 18:32 by allen-yin
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ070300 ѧ˶336Çóµ÷¼Á +5 vvÃÔ 2026-03-21 8/400 2026-03-22 14:20 by ColorlessPI
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û